MX9707899A - Composiciones de analogos de oxitocina y vasopresina para administracion no oral - Google Patents

Composiciones de analogos de oxitocina y vasopresina para administracion no oral

Info

Publication number
MX9707899A
MX9707899A MX9707899A MX9707899A MX9707899A MX 9707899 A MX9707899 A MX 9707899A MX 9707899 A MX9707899 A MX 9707899A MX 9707899 A MX9707899 A MX 9707899A MX 9707899 A MX9707899 A MX 9707899A
Authority
MX
Mexico
Prior art keywords
ions
oxytocin
disinfectant
preservative
sodium
Prior art date
Application number
MX9707899A
Other languages
English (en)
Other versions
MXPA97007899A (es
MX202478B (es
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to MX9707899A priority Critical patent/MX202478B/es
Publication of MX9707899A publication Critical patent/MX9707899A/es
Publication of MXPA97007899A publication Critical patent/MXPA97007899A/es
Publication of MX202478B publication Critical patent/MX202478B/es

Links

MX9707899A 1997-10-14 1997-10-14 Composiciones de analogos de oxitocina y vasopresina para administracion no oral MX202478B (es)

Priority Applications (1)

Application Number Priority Date Filing Date Title
MX9707899A MX202478B (es) 1997-10-14 1997-10-14 Composiciones de analogos de oxitocina y vasopresina para administracion no oral

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MX9707899A MX202478B (es) 1997-10-14 1997-10-14 Composiciones de analogos de oxitocina y vasopresina para administracion no oral

Publications (3)

Publication Number Publication Date
MX9707899A true MX9707899A (es) 1999-04-30
MXPA97007899A MXPA97007899A (es) 1999-05-31
MX202478B MX202478B (es) 2001-06-19

Family

ID=44140756

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9707899A MX202478B (es) 1997-10-14 1997-10-14 Composiciones de analogos de oxitocina y vasopresina para administracion no oral

Country Status (1)

Country Link
MX (1) MX202478B (es)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2161030A1 (en) * 2008-09-09 2010-03-10 Rijksuniversiteit te Groningen Oxytocin formulations and uses thereof

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2161030A1 (en) * 2008-09-09 2010-03-10 Rijksuniversiteit te Groningen Oxytocin formulations and uses thereof
WO2010030180A3 (en) * 2008-09-09 2010-09-10 Rijksuniversiteit Groningen Peptide formulations and uses thereof

Also Published As

Publication number Publication date
MX202478B (es) 2001-06-19

Similar Documents

Publication Publication Date Title
IL141762A0 (en) New oral formulations
HUP0104574A3 (en) Analogues of glp-1, pharmaceutical compositions comprising thereof and their use
HUP0000839A2 (hu) Ciklosporint és egy anionos felületaktív szert tartalmazó szilárd gyógyszerkészítmények és eljárás ezek előállítására
EP1135173A4 (en) MEDICINAL AEROSOL FORMULATION
CA2277824A1 (en) Dosage composition for nasal delivery and method of use of the same
NO20004540L (no) Sammensetninger av peptider, formuleringer og anvendelse derav
MY118151A (en) Pharmaceutical formulations containing voriconazole.
NZ502280A (en) Combination therapy comprising atorvastatin and an antihypertensive agent
HUP0100100A3 (en) Hepatitis c inhibitor peptide analogues, pharmaceutical compositions comprising thereof and their use
BR0109943A (pt) Composições farmacêuticas
HK1029060A1 (en) Pharmaceutical compositions for oral administration, comprising an active substance and a cyclodextrin
HUP0104934A3 (en) Peptide analogues of pacap, pharmaceutical compositions comprising thereof and their use
AP2000001947A0 (en) Novel crystalline forms of an antiviral benzidazole compound.
MY129572A (en) Pharmaceutical preparation containing a cyclopeptide and a chemotherapeutic agent or an angiogenesis inhibitor
AP1424A (en) 2-Phenyl-1-[4-(2-aminoethoxy)-benzyl]-indole in combination with estrogens.
HUP0400832A3 (en) New amidoalkyl-piperidine and amidoalkyl-piperazine derivatives, and pharmaceutical compositions containing such derivatives as active ingredients
BG103714A (en) Pararacetamol-containing tablet
SE0102843D0 (sv) Stabilized oral pharmaceutical composition containing lodide and lodate and method
NZ319138A (en) Composition containing cytochrome complex III and fenazaquin for combatting parasitic fungi
HRP20010937B1 (en) Streptogramin derivatives, preparation and compositions containing them
PL328916A1 (en) Compositions containing inhibitors of hiv protease, such as vx 478 and water-soluble vitamin e compound such as vitamin e-tpgs
PL324690A1 (en) Improved therapeutic agents
HRP20000400B1 (en) Transmucosal formulations of levosimendal
AU7296696A (en) Deodorising formulations containing cationic biopolymers, aluminium chlorhydrate and esterase inhibitors
MX9707899A (es) Composiciones de analogos de oxitocina y vasopresina para administracion no oral

Legal Events

Date Code Title Description
FG Grant or registration
MM Annulment or lapse due to non-payment of fees